Delivery Order SPE2DR25D3103-SPE2DR26F9P84
- Not listed
- The Defense Logistics Agency awarded a $7,161.56 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, an antibiotic pharmaceutical product. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,365.36 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare settings. The award, issued on August 14, 2025, with completion targeted for August 15, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performance...
- The Defense Logistics Agency awarded a delivery order valued at $11,537.13 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 Gram/50s, a broad-spectrum antibiotic used in military and federal healthcare systems. This firm fixed price, non-set-aside contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.22 firm-fixed-price contract is for the delivery of 1 gram vials of the antibiotic Meropenem in 0.9% sodium chloride solution. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,196.33 firm fixed-price delivery order is for the supply of Meropenem-0.9% Sodium Chloride 1 gram/50 units, a critical antibiotic medication. The contract has a completion date of June 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This delivery order, valued at $3,055.46, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Meropenem 0.9% Sodium Chloride (1 gram/50 milliliters) to support federal medical procurement needs. The contract employs firm fixed pricing and carries an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal government's military and...
- The Defense Logistics Agency awarded a delivery order valued at $10,310.23 to AmerisourceBergen Drug Corp for the supply of Meropenem 0.9% Sodium Chloride 1 gram/50s, an antibiotic medication used in military and federal healthcare systems. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of September 22, 2025, and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,464.38, is for the delivery of Meropenem-0.9% Sodium Chloride 1 Gram/50s, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,625.71, is for the supply of MEROPENEM-0.9% NACL 1 GRAM/50S, a pharmaceutical product. The contract has an ultimate completion date of January 3, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $6,323.08 firm-fixed-price delivery order is for the supply of 4,563,934,926 units of Meropenem IV 1 GM Vials, a specialty pharmaceutical product. This delivery order is part of a larger indefinite-delivery contract (IDC) awarded solely to...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9P84Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Meropenem 2 gram vials, a broad-spectrum antibiotic used for serious bacterial infections in military and federal healthcare systems. This firm fixed-price delivery order, valued at $17,036.76, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The award utilized no set-aside designation, indicating competitive selection among qualified vendors. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with DLA and other defense and civilian federal agencies. The company's federal contract awards demonstrate capability across diverse pharmaceutical product categories including specialty medications, generic and brand-name drugs, vaccines, and medical supplies supporting military healthcare programs worldwide. This delivery order for Meropenem vials exemplifies the company's role in supplying essential antibiotics and medications to federal healthcare systems serving the Defense Health Agency, U.S. Coast Guard, and other government medical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 12/15/25 |